You have free access to this content

Hepatology

Cover image for Hepatology

February 2010

Volume 51, Issue 2

Pages 363–725

  1. Introduction to New Section

    1. Top of page
    2. Introduction to New Section
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Diagnostic and therapeutic advances in hepatology: A new feature in the journal (page 363)

      Patrick S. Kamath and Keith D. Lindor

      Version of Record online: 26 JAN 2010 | DOI: 10.1002/hep.23520

  2. Editorials

    1. Top of page
    2. Introduction to New Section
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
  3. Viral Hepatitis

    1. Top of page
    2. Introduction to New Section
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Selection-driven immune escape is not a significant factor in the failure of CD4 T cell responses in persistent hepatitis C virus infection (pages 378–387)

      Michael J. Fuller, Naglaa H. Shoukry, Toshifumi Gushima, David G. Bowen, Benoit Callendret, Katherine J. Campbell, Dana L. Hasselschwert, Austin L. Hughes and Christopher M. Walker

      Version of Record online: 16 NOV 2009 | DOI: 10.1002/hep.23319

    2. You have free access to this content
      Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis (pages 388–397)

      Savino Bruno, Mitchell L. Shiffman, Stuart K. Roberts, Edward J. Gane, Diethelm Messinger, Stephanos J. Hadziyannis and Patrick Marcellin

      Version of Record online: 29 SEP 2009 | DOI: 10.1002/hep.23340

    3. You have free access to this content
      The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response (pages 398–404)

      Elisabeth Lehmann, Walid Hamdy El-Tantawy, Matthias Ocker, Ralf Bartenschlager, Volker Lohmann, Said Hashemolhosseini, Gisa Tiegs and Gabriele Sass

      Version of Record online: 29 SEP 2009 | DOI: 10.1002/hep.23339

    4. You have free access to this content
    5. You have free access to this content
      Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B (pages 415–421)

      Hyun Woong Lee, Heon Ju Lee, Jae Seok Hwang, Joo Hyun Sohn, Jae Young Jang, Ki Jun Han, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yong Han Paik, Chun Kyon Lee, Kwan Sik Lee, Chae Yoon Chon and Kwang-Hyub Han

      Version of Record online: 9 NOV 2009 | DOI: 10.1002/hep.23323

    6. You have free access to this content
      Entecavir treatment for up to 5 years in patients with hepatitis B e antigen–positive chronic hepatitis B (pages 422–430)

      Ting-Tsung Chang, Ching-Lung Lai, Seung Kew Yoon, Samuel S. Lee, Henrique Sergio M. Coelho, Flair Jose Carrilho, Fred Poordad, Waldemar Halota, Yves Horsmans, Naoky Tsai, Hui Zhang, Daniel J. Tenney, Ricardo Tamez and Uchenna Iloeje

      Version of Record online: 4 JAN 2010 | DOI: 10.1002/hep.23327

    7. You have free access to this content
      Prevalence of hepatitis B surface antigen among refugees entering the United States between 2006 and 2008 (pages 431–434)

      David B. Rein, Sarah B. Lesesne, Ann O'Fallon and Cindy M. Weinbaum

      Version of Record online: 29 SEP 2009 | DOI: 10.1002/hep.23353

    8. You have free access to this content
  4. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Introduction to New Section
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial (pages 445–453)

      Vlad Ratziu, Fréderic Charlotte, Carole Bernhardt, Philippe Giral, Marine Halbron, Gilles LeNaour, Agnès Hartmann-Heurtier, Eric Bruckert, Thierry Poynard and LIDO Study Group

      Version of Record online: 9 SEP 2009 | DOI: 10.1002/hep.23270

    2. You have free access to this content
      Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease (pages 454–462)

      Vincent Wai-Sun Wong, Julien Vergniol, Grace Lai-Hung Wong, Juliette Foucher, Henry Lik-Yuen Chan, Brigitte Le Bail, Paul Cheung-Lung Choi, Mathurin Kowo, Anthony Wing-Hung Chan, Wassil Merrouche, Joseph Jao-Yiu Sung and Victor de Lédinghen

      Version of Record online: 9 SEP 2009 | DOI: 10.1002/hep.23312

    3. You have free access to this content
      Lack of interleukin-6/glycoprotein 130/signal transducers and activators of transcription-3 signaling in hepatocytes predisposes to liver steatosis and injury in mice (pages 463–473)

      Daniela C. Kroy, Naiara Beraza, Darjus F. Tschaharganeh, Leif E. Sander, Stephanie Erschfeld, Arne Giebeler, Christian Liedtke, Hermann E. Wasmuth, Christian Trautwein and Konrad L. Streetz

      Version of Record online: 16 NOV 2009 | DOI: 10.1002/hep.23322

    4. You have free access to this content
      Toxicant-associated steatohepatitis in vinyl chloride workers (pages 474–481)

      Matt Cave, Keith Cameron Falkner, Mukunda Ray, Swati Joshi-Barve, Guy Brock, Rehan Khan, Marjorie Bon Homme and Craig J. McClain

      Version of Record online: 9 NOV 2009 | DOI: 10.1002/hep.23321

    5. You have free access to this content
      Gamma-glutamyltransferase and disability pension: A cohort study of construction workers in Germany (pages 482–490)

      Heiner Claessen, Hermann Brenner, Christoph Drath and Volker Arndt

      Version of Record online: 4 DEC 2009 | DOI: 10.1002/hep.23324

    6. You have free access to this content
      Variability in ethanol biodisposition in whites is modulated by polymorphisms in the ADH1B and ADH1C genes (pages 491–500)

      Carmen Martínez, Segismundo Galván, Elena Garcia-Martin, María I. Ramos, Yolanda Gutiérrez-Martín and José A.G. Agúndez

      Version of Record online: 29 SEP 2009 | DOI: 10.1002/hep.23341

    7. You have free access to this content
      Hemochromatosis in Italy in the last 30 years: Role of genetic and acquired factors (pages 501–510)

      Anna Ludovica Fracanzani, Alberto Piperno, Luca Valenti, Mirella Fraquelli, Sabina Coletti, Alessandra Maraschi, Dario Consonni, Enzo Coviello, Dario Conte and Silvia Fargion

      Version of Record online: 1 OCT 2009 | DOI: 10.1002/hep.23333

    8. You have free access to this content
      Kupffer cells promote hepatic steatosis via interleukin-1β–dependent suppression of peroxisome proliferator-activated receptor α activity (pages 511–522)

      Rinke Stienstra, Fredy Saudale, Caroline Duval, Shohreh Keshtkar, Johanna E. M. Groener, Nico van Rooijen, Bart Staels, Sander Kersten and Michael Müller

      Version of Record online: 29 SEP 2009 | DOI: 10.1002/hep.23337

  5. Hepatobiliary Malignancies

    1. Top of page
    2. Introduction to New Section
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
    2. You have free access to this content
      Liver cancer: EphrinA2 promotes tumorigenicity through Rac1/Akt/NF-κB signaling pathway (pages 535–544)

      Yu-Xiong Feng, Jiang-Sha Zhao, Jing-Jing Li, Tao Wang, Shu-Qun Cheng, Yunfei Yuan, Fudi Wang, Xiao-Fan Wang and Dong Xie

      Version of Record online: 14 SEP 2009 | DOI: 10.1002/hep.23313

    3. You have free access to this content
      Expression and functional significance of Twist1 in hepatocellular carcinoma: Its role in vasculogenic mimicry (pages 545–556)

      Tao Sun, Nan Zhao, Xiu-lan Zhao, Qiang Gu, Shi-wu Zhang, Na Che, Xing-hui Wang, Jing Du, Yi-xin Liu and Bao-cun Sun

      Version of Record online: 9 SEP 2009 | DOI: 10.1002/hep.23311

    4. You have free access to this content
      Loss of hepatocyte nuclear factor 1α function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis (pages 557–566)

      Laura Pelletier, Sandra Rebouissou, Alain Paris, Estelle Rathahao-Paris, Elisabeth Perdu, Paulette Bioulac-Sage, Sandrine Imbeaud and Jessica Zucman-Rossi

      Version of Record online: 5 OCT 2009 | DOI: 10.1002/hep.23362

  6. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Introduction to New Section
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      CX3CL1 (fractalkine): A signpost for biliary inflammation in primary biliary cirrhosis (pages 567–575)

      Shinji Shimoda, Kenichi Harada, Hiroaki Niiro, Akinobu Taketomi, Yoshihiko Maehara, Koichi Tsuneyama, Kentaro Kikuchi, Yasuni Nakanuma, Ian R. Mackay, M. Eric Gershwin and Koichi Akashi

      Version of Record online: 11 NOV 2009 | DOI: 10.1002/hep.23318

  7. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Introduction to New Section
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome (pages 576–584)

      Lise L. Gluud, Kurt Christensen, Erik Christensen and Aleksander Krag

      Version of Record online: 9 SEP 2009 | DOI: 10.1002/hep.23286

    2. You have free access to this content
      Prognostic value of Ishak fibrosis stage: Findings from the hepatitis C antiviral long-term treatment against cirrhosis trial (pages 585–594)

      James E. Everhart, Elizabeth C. Wright, Zachary D. Goodman, Jules L. Dienstag, John C. Hoefs, David E. Kleiner, Marc G. Ghany, A. Scott Mills, S. Russell Nash, Sugantha Govindarajan, Thomas E. Rogers, Joel K. Greenson, Elizabeth M. Brunt, Herbert L. Bonkovsky, Chihiro Morishima, Heather J. Litman and HALT-C Trial Group

      Version of Record online: 14 SEP 2009 | DOI: 10.1002/hep.23315

    3. You have free access to this content
      Decreased survival of subjects with elevated liver function tests during a 28-year follow-up (pages 595–602)

      Cecilia Söderberg, Per Stål, Johan Askling, Hans Glaumann, Greger Lindberg, Joel Marmur and Rolf Hultcrantz

      Version of Record online: 14 SEP 2009 | DOI: 10.1002/hep.23314

    4. You have free access to this content
      Chronic administration of valproic acid inhibits activation of mouse hepatic stellate cells in vitro and in vivo (pages 603–614)

      Inge Mannaerts, Nele R. Nuytten, Vera Rogiers, Karin Vanderkerken, Leo A. van Grunsven and Albert Geerts

      Version of Record online: 1 OCT 2009 | DOI: 10.1002/hep.23334

  8. Liver Injury/Regeneration

    1. Top of page
    2. Introduction to New Section
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events (pages 615–620)

      Craig Lammert, Einar Bjornsson, Anna Niklasson and Naga Chalasani

      Version of Record online: 14 SEP 2009 | DOI: 10.1002/hep.23317

    2. You have free access to this content
      Toll-like receptor 9 inhibition confers protection from liver ischemia–reperfusion injury (pages 621–632)

      Zubin M. Bamboat, Vinod P. Balachandran, Lee M. Ocuin, Hebroon Obaid, George Plitas and Ronald P. DeMatteo

      Version of Record online: 5 OCT 2009 | DOI: 10.1002/hep.23365

  9. Liver Biology/Pathobiology

    1. Top of page
    2. Introduction to New Section
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      The homeobox gene Hex regulates hepatocyte differentiation from embryonic stem cell–derived endoderm (pages 633–641)

      Atsushi Kubo, Yon Hui Kim, Stefan Irion, Shogo Kasuda, Mitsuaki Takeuchi, Kazuo Ohashi, Masayuki Iwano, Yoshiko Dohi, Yoshihiko Saito, Ralph Snodgrass and Gordon Keller

      Version of Record online: 9 SEP 2009 | DOI: 10.1002/hep.23293

    2. You have free access to this content
      Integrated approach for the identification of human hepatocyte nuclear factor 4α target genes using protein binding microarrays (pages 642–653)

      Eugene Bolotin, Hailing Liao, Tuong Chi Ta, Chuhu Yang, Wendy Hwang-Verslues, Jane R. Evans, Tao Jiang and Frances M. Sladek

      Version of Record online: 5 OCT 2009 | DOI: 10.1002/hep.23357

  10. Rapid Communication

    1. Top of page
    2. Introduction to New Section
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Huh-7: A human “hemochromatotic” cell line (pages 654–659)

      Chiara Vecchi, Giuliana Montosi and Antonello Pietrangelo

      Version of Record online: 27 OCT 2009 | DOI: 10.1002/hep.23410

  11. AASLD Practice Guideline

    1. Top of page
    2. Introduction to New Section
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Diagnosis and management of primary sclerosing cholangitis (pages 660–678)

      Roger Chapman, Johan Fevery, Anthony Kalloo, David M. Nagorney, Kirsten Muri Boberg, Benjamin Shneider and Gregory J. Gores

      Version of Record online: 9 SEP 2009 | DOI: 10.1002/hep.23294

  12. Reviews

    1. Top of page
    2. Introduction to New Section
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
    2. You have free access to this content
      Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: An analytical review (pages 690–698)

      Lingyi Zhang, Guqi Wang, Weihong Hou, Ping Li, Andrea Dulin and Herbert L. Bonkovsky

      Version of Record online: 19 OCT 2009 | DOI: 10.1002/hep.23384

  13. Diagnostic and Therapeutic Advances in Hepatology

    1. Top of page
    2. Introduction to New Section
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
  14. Hepatology Elsewhere

    1. Top of page
    2. Introduction to New Section
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Snipping away at hepatitis C (pages 703–705)

      Nicholas A. Shackel, David G. Bowen and Geoffrey W. McCaughan

      Version of Record online: 26 JAN 2010 | DOI: 10.1002/hep.23490

    2. You have free access to this content
    3. You have free access to this content
      A glimpse of future hepatitis C virus treatment paradigms (pages 707–710)

      Norah Terrault and Mandana Khalili

      Version of Record online: 26 JAN 2010 | DOI: 10.1002/hep.23523

  15. Image of the Month

    1. Top of page
    2. Introduction to New Section
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      The bright liver of glycogenic hepatopathy (pages 711–712)

      Seth Sweetser and Robert E. Kraichely

      Version of Record online: 23 OCT 2009 | DOI: 10.1002/hep.23402

  16. Correspondence

    1. Top of page
    2. Introduction to New Section
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Extrahepatic conditions associated with primary biliary cirrhosis (page 713)

      Ricardo Moreno-Otero and María Trapero-Marugán

      Version of Record online: 10 AUG 2009 | DOI: 10.1002/hep.23231

    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
    6. You have free access to this content
      Comment on “angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice” (page 718)

      Michael G. Lenos and Sofia-Maria Tsaniklidou

      Version of Record online: 29 SEP 2009 | DOI: 10.1002/hep.23350

    7. You have free access to this content
    8. You have free access to this content
    9. You have free access to this content
      From liver markers to life expectancy (page 720)

      Chia-Chi Wang and Jia-Horng Kao

      Version of Record online: 30 NOV 2009 | DOI: 10.1002/hep.23452

    10. You have free access to this content
      Reply: (pages 720–721)

      Robin Haring, Henri Wallaschofski, Matthias Nauck, Marcus Dörr, Sebastian E. Baumeister and Henry Völzke

      Version of Record online: 8 DEC 2009 | DOI: 10.1002/hep.23494

    11. You have free access to this content
      Clodronate liposomes: All sites of injection are not equal (pages 721–722)

      Nicolas Lanthier, Yves Horsmans and Isabelle A. Leclercq

      Version of Record online: 30 NOV 2009 | DOI: 10.1002/hep.23455

    12. You have free access to this content
      Reply: (page 722)

      Sander Kersten, Rinke Stienstra and Michael Müller

      Version of Record online: 8 DEC 2009 | DOI: 10.1002/hep.23495

    13. You have free access to this content
      Radiofrequency ablation must be assessed by pathological methods (page 723)

      Juan C. Rodríguez-Sanjuán, Francisco González and Manuel Gómez-Fleitas

      Version of Record online: 30 NOV 2009 | DOI: 10.1002/hep.23454

    14. You have free access to this content
      Reply: (pages 723–724)

      Gisele N'Kontchou, Michel Beaugrand and Olivier Seror

      Version of Record online: 23 DEC 2009 | DOI: 10.1002/hep.23513

  17. Corrections

    1. Top of page
    2. Introduction to New Section
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Rapid Communication
    12. AASLD Practice Guideline
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Corrections (page 725)

      Version of Record online: 26 JAN 2010 | DOI: 10.1002/hep.23503

    2. You have free access to this content
      Corrections (page 725)

      Version of Record online: 26 JAN 2010 | DOI: 10.1002/hep.23508

SEARCH

SEARCH BY CITATION